Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2008 Nov;33(4):475-82.
doi: 10.1007/s12038-008-0066-z.

Emerging influenza virus: a global threat

Affiliations
Review

Emerging influenza virus: a global threat

M Khanna et al. J Biosci. 2008 Nov.

Abstract

Since 1918, in?uenza virus has been one of the major causes of morbidity and mortality, especially among young children. Though the commonly circulating strain of the virus is not virulent enough to cause mortality, the ability of the virus genome to mutate at a very high rate may lead to the emergence of a highly virulent strain that may become the cause of the next pandemic. Apart from the influenza virus strain circulating in humans (H1N1 and H3N2), the avian influenza H5N1 H7 and H9 virus strains have also been reported to have caused human infections, H5N1 H7 and H9 have shown their ability to cross the species barrier from birds to humans and further replicate in humans. This review addresses the biological and epidemiological aspects of influenza virus and efforts to have a control on the virus globally.

PubMed Disclaimer

References

    1. Abed Y., Goyette N., Boivin G. Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob. Agents Chemother. 2005;49:556–559. doi: 10.1128/AAC.49.2.556-559.2005. - DOI - PMC - PubMed
    1. Areechokchai D., Jiraphongsa C., Laosiritaworn Y., Hanshaoworakul W., O’Reilly M. Investigation of avian influenza (H5N1) outbreak in humans—Thailand, 2004. Morb. Mortal. Wkly Rep. 2006;55:3–6. - PubMed
    1. Belshe R. B., Gruber W. C., Mendelman P. M., Mehata H. B., Mahmood K., Reisinger K., Treanor J., Zangwill K., et al. Correlates of imune protection induced by live, attenuated, cold adapted, trivalent, intranasal influenza virus vaccine. J. Infect. Dis. 2000;181:1133–1137. doi: 10.1086/315323. - DOI - PubMed
    1. Belshe R. B., Gruber W. C., Mendelman P. M., Cho I., Reisinger K., Block S. L., Wittes J., Iacuzio D., et al. Efficacy of vaccination with live atteuated, cold adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sidney) not contained in the vaccine. J. Pediatr. 2000;136:168–175. doi: 10.1016/S0022-3476(00)70097-7. - DOI - PubMed
    1. Belshe R. B., Smith H. M., Hall C. B., Betts R., Hay A. J. Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. J. Virol. 1988;62:1508–1512. - PMC - PubMed

MeSH terms

Substances